(StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))
This gene encodes a protein which contains an N-terminal sterile alpha motif (SAM) for protein-protein interactions, followed by an ATP/GTP-binding motif, a GTPase-activating protein (GAP) domain, and a C-terminal STAR-related lipid transfer (START) domain. It may be involved in regulation of cytoskeletal reorganization, cell proliferation, and cell motility, and acts as a tumor suppressor in hepatoma cells. The gene is located in a region of chromosome 13 that is associated with loss of heterozygosity in hepatocellular carcinomas. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011].
Zhang, Wang, Hu: "STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas." in: Biotechnology letters, Vol. 39, Issue 2, pp. 207-217, (2017) (PubMed).
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).
Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).
Aliases for STARD13 抗体
StAR related lipid transfer domain containing 13 (STARD13) 抗体 StAR-related lipid transfer (START) domain containing 13 (Stard13) 抗体 StAR-related lipid transfer domain containing 13 (Stard13) 抗体 ARHGAP37 抗体 DLC2 抗体 GT650 抗体 LINC00464 抗体 RGD1564816 抗体